Corium, the molten core material generated during severe nuclear reactor accidents, presents complex challenges in terms of its behaviour and the associated heat transfer mechanisms.

Corium has the consistency of lava and is made up of many things, including nuclear fuel, ... The Elephant’s Foot is a large mass comprised of black corium and has many layers.

What happened Corium International (NASDAQ: CORI) is down 11% at 11:58 a.m. EST after announcing that it priced $100 million of 5% convertible.

The manufacturing business, named Corium Pharma Solutions, Inc. (“Corium Pharma Solutions”), transacted with an investment by Webster for more than $400 million in value.

Corium International, Inc. CORI, +7.04% a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today ...

35 years ago, during the catastrophic reactor core meltdown at the Chernobyl Nuclear Power Station, a dangerously radioactive variety of lava, named corium, formed.

Corium Innovations, Inc. , a leading, full-service contract development and manufacturing organization specializing in novel drug delivery technologies, announced today that it will be featuring ...

Corium’s original investor, Gurnet Point Capital (“Gurnet Point”), remains as a joint owner in Corium Pharma Solutions and each Gurnet Point and Webster have equal board representation.

Corium's share surged 52.8% on Oct 12 following the announcement. Shares of the company have rallied 32.1% so far this year against the industry 's decline of 2%.. Corium is a commercial-stage ...

Shares of Corium International (NASDAQ: CORI), a commercial-stage biopharmaceutical company focused on transdermal and transmucosal delivery systems, were up 50% as of 11:10 a.m. EDT on Friday ...

Corium's successful offering marks the first biotech IPO of the second quarter, following a remarkable Q1 in which 29 life sciences companies raised a combined $2.1 billion on the public markets.